Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

BBS-Bioactive Bone Substitutes

3,902 following
Overview
Investor consensus
All
Research
Webcasts
Press releases
ShowingAll content types
Regulatory press release3/5/2025, 12:30 PM

BBS-Bioactive Bone Substitutes Plc Apply for Delisting from Nasdaq First North

BBS-Bioactive Bone Substitutes
Regulatory press release2/20/2025, 7:00 PM

BBS-Bioactive Bone Substitutes Plc: Financial calendar and Bankruptcy

BBS-Bioactive Bone Substitutes
Regulatory press release2/17/2025, 11:15 AM

BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc has been declared bankrupt

BBS-Bioactive Bone Substitutes

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2/12/2025, 3:00 PM

BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc Files for Bankruptcy

BBS-Bioactive Bone Substitutes
Regulatory press release2/10/2025, 7:00 AM

BBS-Bioactive Bone Substitutes Plc: Situational information about measures to be taken to secure the company's financial situation and operations

BBS-Bioactive Bone Substitutes
Regulatory press release2/6/2025, 1:00 PM

BBS-Bioactive Bone Substitutes Plc: Financial manager Annastiina Kauppinen resigns from the Company

BBS-Bioactive Bone Substitutes
Regulatory press release1/31/2025, 2:30 PM

BBS-Bioactive Bone Substitutes Plc: The Finnish Financial Supervisory Authority has imposed a penalty payment on a two current and one former member of Company’s Board of Directors

BBS-Bioactive Bone Substitutes
Regulatory press release12/18/2024, 12:00 PM

Correction: BBS-Bioactive Bone Substitutes Oyj – Insider information: CEO Juliusz Rakowski has terminated the CEO agreement

BBS-Bioactive Bone Substitutes
Regulatory press release12/18/2024, 11:00 AM

BBS-Bioactive Bone Substitutes Oyj – Changes in the Management team: CEO Juliusz Rakowski has terminated the CEO agreement

BBS-Bioactive Bone Substitutes
Regulatory press release12/13/2024, 11:00 AM

BBS-Bioactive Bone Substitutes Plc: Financial calendar and Annual General Meeting in 2025

BBS-Bioactive Bone Substitutes
Regulatory press release12/13/2024, 7:30 AM

BBS-Bioactive Bone Substitutes Plc – Insider information: The results of change negotiations

BBS-Bioactive Bone Substitutes
Life Science Companies as Investments | Life Science Night Dec. 2, 2024
Video12/2/2024, 2:00 PM

Life Science Companies as Investments | Life Science Night Dec. 2, 2024

Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.

Aiforia TechnologiesBBS-Bioactive Bone SubstitutesBioretecBiohitFaron PharmaceuticalsModulightNexstimOrionBittiumDetection TechnologyOptomedRevenio GroupNightingale HealthHerantis PharmaNanoform Finland
Regulatory press release11/29/2024, 2:30 PM

BBS-Bioactive Bone Substitutes Plc – Insider information: BBS updates its action plans

BBS-Bioactive Bone Substitutes
Regulatory press release11/29/2024, 2:20 PM

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes
Regulatory press release11/29/2024, 1:00 PM

BBS-Bioactive Bone Substitutes Plc: Production Director Kimmo Tyni resigns from the Company

BBS-Bioactive Bone Substitutes
Regulatory press release11/26/2024, 3:00 PM

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes
Regulatory press release11/22/2024, 5:05 PM

BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself

BBS-Bioactive Bone Substitutes
Regulatory press release11/22/2024, 5:00 PM

BBS-Bioactive Bone Substitutes Plc – Insider information: BBS will start change negotiations

BBS-Bioactive Bone Substitutes
Regulatory press release11/14/2024, 12:00 PM

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes
Regulatory press release11/7/2024, 11:00 AM

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.